intellectual property
NowDx Countersues OraSure in Ongoing Legal Battle Over Point-of-Care Trade Secrets
Following OraSure's November 2024 lawsuit accusing NowDx of misappropriating trade secrets, NowDx has countersued OraSure over similar allegations.
Editas Medicine Raises $57M by Selling Future Payments From CRISPR Licensing Deal With Vertex Pharma
Editas will receive $57 million in upfront cash from DRI Healthcare Trust in exchange for certain future licensing fees and payments it is owed under an earlier deal with Vertex.
T2 Biosystems Pathogen Detection Patent Upheld in Europe
French diagnostics maker BioMérieux and other undisclosed firms had filed an opposition to the patent in May 2023.
ERS Genomics CRISPR Patent Upheld in China
The Chinese patent office decision marks the latest ruling in a series of challenges to ERS Genomics' patent estate that have been filed around the world.
MilliporeSigma Licenses CRISPR IP to Huntington's Disease Research Nonprofit
The license will allow the nonprofit to edit cell lines and perform other research related to the discovery and development of therapies for Huntington's disease.